Prospective evidence discourages secondary cytoreductive surgery
Sign Up to like & getrecommendations! Published in 2019 at "Nature Reviews Clinical Oncology"
DOI: 10.1038/s41571-019-0309-y
Abstract: (2019) For decades, patients with recurrent ovarian cancer have undergone secondary cytoreductive surgery (SCS). “The prevailing opinion, based on retrospective series and included in the National Comprehensive Cancer Network guidelines, was that surgery should be… read more here.
Keywords: chemotherapy; secondary cytoreductive; surgery; durations months ... See more keywords